Evidence map›Paper›PMID 27315794›Full record

ArticleBMC genomics2016

EventPointer: an effective identification of alternative splicing events using junction arrays.

Juan P Romero, Ander Muniategui, Fernando J De Miguel, Ander Aramburu, Luis Montuenga, Ruben Pio, Angel Rubio

Abstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Neurofibromin 1 (International journal of molecular sciences · 2026
    Article
  3. The cancer-associated SF3B1Cell death & disease · 2025
    Article
  4. Article
  5. Article
  6. Alternative splicing analysis benchmark with DICAST.NAR genomics and bioinformatics · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juan P RomeroCEIT, Parque Tecnológico de San Sebastián, Paseo Mikeletegi 48, 20009, San Sebastián, Gipuzkoa, Spain.
Ander MuniateguiCEIT, Parque Tecnológico de San Sebastián, Paseo Mikeletegi 48, 20009, San Sebastián, Gipuzkoa, Spain.
Fernando J De MiguelProgram in Solid Tumors and Biomarkers, CIMA, University of Navarra, Avda. Pío XII, 55, E-31008, Pamplona, Navarra, Spain.
Ander AramburuCEIT, Parque Tecnológico de San Sebastián, Paseo Mikeletegi 48, 20009, San Sebastián, Gipuzkoa, Spain.
Luis MontuengaProgram in Solid Tumors and Biomarkers, CIMA, University of Navarra, Avda. Pío XII, 55, E-31008, Pamplona, Navarra, Spain.
Ruben PioProgram in Solid Tumors and Biomarkers, CIMA, University of Navarra, Avda. Pío XII, 55, E-31008, Pamplona, Navarra, Spain.
Angel RubioCEIT, Parque Tecnológico de San Sebastián, Paseo Mikeletegi 48, 20009, San Sebastián, Gipuzkoa, Spain. arubio@ceit.es.ORCID 0000-0002-3274-2450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlternative splicing (AS) is a major source of variability in the transcriptome of eukaryotes. There is an increasing interest in its role in different pathologies. Before sequencing technology appeared, AS was measured with specific arrays. However, these arrays did not perform well in the detection of AS events and provided very large false discovery rates (FDR). Recently the Human Transcriptome Array 2.0 (HTA 2.0) has been deployed. It includes junction probes. However, the interpretation software provided by its vendor (TAC 3.0) does not fully exploit its potential (does not study jointly the exons and junctions involved in a splicing event) and can only be applied to case-control studies. New statistical algorithms and software must be developed in order to exploit the HTA 2.0 array for event detection.

resultsWe have developed EventPointer, an R package (built under the aroma.affymetrix framework) to search and analyze Alternative Splicing events using HTA 2.0 arrays. This software uses a linear model that broadens its application from plain case-control studies to complex experimental designs. Given the CEL files and the design and contrast matrices, the software retrieves a list of all the detected events indicating: 1) the type of event (exon cassette, alternative 3', etc.), 2) its fold change and its statistical significance, and 3) the potential protein domains affected by the AS events and the statistical significance of the possible enrichment. Our tests have shown that EventPointer has an extremely low FDR value (only 1 false positive within the tested top-200 events). This software is publicly available and it has been uploaded to GitHub.

conclusionsThis software empowers the HTA 2.0 arrays for AS event detection as an alternative to RNA-seq: simplifying considerably the required analysis, speeding it up and reducing the required computational power.

Indexed as

Alternative SplicingOligonucleotide Array Sequence AnalysisSoftwareAlgorithmsComputational BiologyGene Expression ProfilingMolecular Sequence AnnotationReproducibility of ResultsTranscriptomeUser-Computer InterfaceAlternative splicingJunction microarraysProtein domains

Identifiers

PMID27315794
PMCPMC4912780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.